IL-6 in PACVS

In PACVS (PACVS, PCVS), published studies report higher levels of IL-6, also described as Pro-inflammatory cytokine, than in healthy controls. Clinically, it has been associated with elevated in >80% of PACVS registry cohort. The evidence summarised here comes from Mundorf et al. 2024 and reflects averages across cohorts rather than any single patient's result.

↑ ElevatedInflammatoryLOINC 26881-5

Summary

Direction in PACVS↑ Elevated — higher than in the comparison group
CategoryInflammatory
Also described asPro-inflammatory cytokine
Compared againstHC (healthy controls)
Associated symptomsElevated in >80% of PACVS registry cohort
Test typeBlood test (serum / plasma / whole blood)
LOINC code26881-5
SourceMundorf et al. 2024 — doi:10.3390/vaccines12070790
Condition atlasPACVS Biomarker Atlas

Other conditions where Interleukin-6 (IL-6) is reported

See the cross-condition hub: Interleukin-6 (IL-6) across conditions.

Trials, interventions and tests

Commercial test availability

Interleukin-6 (IL-6), Serum — commercial laboratory test.

Links are for reference only; availability, specimen requirements and coverage vary by location.

Related Inflammatory markers in PACVS

Full list: PACVS Biomarker Atlas.

Frequently asked questions

Is IL-6 high or low in PACVS?

Elevated. Studies summarised in the OSMF atlas report higher IL-6 in PACVS than in healthy controls. Source: Mundorf et al. 2024.

What symptoms is IL-6 associated with in PACVS?

The cited literature associates this marker with Elevated in >80% of PACVS registry cohort. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures IL-6?

It is measured as a blood test (serum / plasma / whole blood). The standard laboratory code is LOINC 26881-5. Commercial laboratories such as Quest Diagnostics, LabCorp, Ulta Lab Tests list an orderable assay.

Is one abnormal IL-6 result diagnostic of PACVS?

No. No single biomarker is diagnostic of PACVS. IL-6 findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Is IL-6 specific to PACVS?

No. The same marker is also reported in Gulf War Illness, Long COVID, Low Back Pain, Lyme Disease, ME/CFS, Major Depressive Disorder, Rheumatoid Arthritis in this atlas, so it reflects shared biology (for example inflammation or vascular stress) rather than a condition-specific signature.

Cite this page

Open Source Medicine Foundation. (2026). IL-6 in PACVS: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/pacvs/il-6.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-30 · Page generated from pacvs.json · Browse: PACVS atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.